Sudhir Manda is an Oncology physician affiliated with Tucson Medical Center. OpenAlex indexes 56 publications with 674 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
603 N Wilmot Rd
Ste. # 151
Tucson, AZ 857112701
Telephone
520-886-0206Provider last certified this registry record 9 Mar 2022.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202513 payments
- PFIZER INC.Program year202510 payments
- Celgene CorporationProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44.2%CD38-directed Cytolytic Antibody24%Daratumumab100%Part B, office-administered≥14 patientsMicrotubule Inhibitor10.3%Paclitaxel100%Part B, office-administered≥12 patients+ 6 more classes in this area
Blood & clotting
24.7%Erythropoiesis-stimulating Agent20.6%Darbepoetin alfa100%Part B, office-administered≥13 patientsIron, parenteral preparations4.1%Ferric derisomaltose100%Part B, office-administered≥13 patients+ 1 more class in this area
Metabolism & gastrointestinal
18.8%Other antiemetics13.9%Fosaprepitant100%Part B, office-administered≥21 patientsSerotonin-3 Receptor Antagonist4.8%Granisetron hydrochloride63%Palonosetron hcl33%Ondansetron Hcl2%Ondansetron Odt2%Part D + Part B≥36 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Buscema, MD
Tucson Medical Center
Neil Gheewala, MD
Tucson Medical Center
Sreekanth Vasireddy, MD
Tucson Medical Center
Christine Farinelli, MD
Tucson Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”